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Abstract
Our previous study showed that KG-1, a human acute
leukemia cell line, has mutational loss of 8-oxoguanine
(8-hydroxyguanine; oh8Gua) glycosylase 1 (OGG1)
activity and that its viability is severely affected by
8-hydroxydeoxyguanosine (8-oxodeoxyguanosine;
oh8dG). In the present study, the nature of the killing
action of oh8dG on KG-1 was investigated. Signs
observed in oh8dG-treated KG-1 cells indicated that
death was due to apoptosis, as demonstrated by:
increased sub-G1 hypodiploid (apoptotic) cells, DNA
fragmentation, and apoptotic body formation; loss of
mitochondrial transmembrane potential, the release of
cytochrome c from mitochondria into the cytosol, and
the down-regulation of bcl-2; and the activation of
caspases 8, 9, and 3, and the efficient inhibition of the
apoptotic process by caspases inhibitors. This
apoptosis appears not to be associated with Fas/Fas
ligand because the expressions of these proteins were
unchanged. Apoptotic KG-1 cells showed a high
concentration of oh8Gua in DNA. Moreover, the
increased concentration of oh8Gua in DNA, and the
apoptotic process were not suppressed by the
antioxidant, N-acetylcysteine, and thus the process is
independent of reactive oxygen species. Of the 18
cancer cell lines treated with oh8dG, 3 cell lines
(H9, CEM-CM3, and Molt-4) were found to be committed
to apoptosis, and all of these showed very low OGG1
activity and a marked increase in the concentration of
oh8Gua in DNA. These observations indicate that in
addition to its mutagenic action, oh8Gua in DNA
disturbs cell viability by inducing apoptosis.
Introduction
In spite of its facile formation in the presence of reactive
oxygen species (ROS), knowledge of the action of 8-
hydroxyguanine (8-oxoguanine; oh8Gua) in DNA is limited
to its mutagenicity. Moreover, even this action is the result of
speculation based on in vitro observations, such as, the
mismatch of oh8Gua with A instead of C and the resulting
GC!TA transversion. These relationships are demonstrated
by a DNA polymerase reaction using an oh8Gua containing
an oligonucleotide template (1, 2), or by indirect in vivo
data, such as the high or low mutation rates observed in cells
with a deficiency or a supplementation of oh8Gua’s repair
enzyme, which is known as 8-oxoguanine glycosylase 1
(OGG1) (3, 4). Nevertheless, many chemicals or forms of
radiation that produce ROS cause various cytotoxic changes
in cells and increase the oh8Gua level in DNA. Thus, some
of these cytotoxic changes are expected to be mediated by
the oh8Gua in DNA formed by generated ROS (5, 6).
However, conclusive evidence of this mediation is unavail-
able because such ROS-producing agents cause modifications
in DNA other than the production of oh8Gua, and, therefore,
the exclusive formation of oh8Gua in cellular DNA has never
been observed.
KG-1 is an acute leukemia cell line, which has no OGG1
activity because of a mutation in the OGG1 gene. In a
previous study, we found that this cell line when treated with
8-hydroxydeoxyguanosine (a nucleoside of oh8Gua; oh8dG),
shows a high level of oh8Gua in its DNA and dies (7). This
result suggests that the death of oh8dG-treated KG-1 is due
to an increased level of oh8Gua in DNA and implies that
oh8Gua in DNA can be lethal. In the present study, we
attempted to elucidate the mode of action of oh8Gua in DNA
by studying the nature of the oh8dG that induces the death of
KG-1, and to determine the relation between the cell-killing
action of oh8dG and OGG1 deficiency. Our results show
that oh8dG-induced cell death is mediated by an apoptotic
process and we suggest that this is another function of
oh8Gua in DNA.
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Results
Death of KG-1 Cells and Increased oh8Gua Level in DNA
After oh8dG Treatment
KG-1 cells deficient in OGG1 activity were treated with
oh8dG, and their viability and oh8Gua levels in DNA were
determined. As shown in Fig. 1, the viability of KG-1 cells, as
determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT) test, was severely affected by
oh8dG in a time-dependent (Fig. 1A) and dose-dependent
(Fig. 1B) manner. After 96 h incubation, 50% of KG-1 cells
were killed by 50 Ag/ml of oh8dG (Fig. 1B). At the same time,
the concentration of oh8Gua in DNA increased in a time- and
dose-dependent fashion (Fig. 1C). In contrast, U937 cell line
with normal OGG1 activity showed almost no changes in
viability or in oh8Gua level in DNA.
Induction of Apoptosis in oh8dG-Treated KG-1 Cells
To determine the cause of KG-1 death by oh8dG (Fig. 1,
A and B), apoptosis was examined in different ways. First,
the appearance of sub-G1 hypodiploid cells, which are known
to be apoptotic cells (8), was examined by flow cytometry.
As shown in Fig. 2A, the proportion of these apoptotic cells
in oh8dG-treated KG-1 cells dramatically increased in a time-
and dose-dependent manner. Apoptotic body formation
(Fig. 2B) was also observed microscopically and through
DNA fragmentation by electrophoresis (Fig. 2C), both of
which are indicators of apoptosis (9). Here again, U937
showed almost no changes in terms of these three criteria,
i.e. , the number of sub-G1 hypodiploid cells, apoptotic body
formation, and DNA fragmentation.
Changes in Proteins Involved in the Apoptotic Process
To understand the mechanistic background of oh8dG-
induced apoptosis, we first examined changes in the amounts
of Bax and Bcl-2 by Western blot. As shown in Fig. 3, the
amount of Bax, a pro-apoptotic protein, showed no change.
However, Bcl-2, an anti-apoptotic protein, decreased gradually
with time. One of the actions of Bcl-2 during the apoptotic
process is to prevent the opening of mitochondrial membrane
pores (10). It is suggested that pore opening induces the
disruption of Dum, which in turn leads to the release of
cytochrome c from mitochondria (11). Therefore, the low level
of Bcl-2 (Fig. 3) may augment these mitochondrial events in
oh8dG-treated KG-1 cells. Fig. 4A shows the increased
proportion of cells with disrupted Dum versus time after
KG-1 cells were treated with oh8dG. Interestingly, the kinetics
of cell increase versus a loss of Dum (Fig. 4A) coincided
precisely with the increase of apoptotic sub-G1 hypodiploid
cells (Fig. 4C). Fig. 4B shows a decreased level of cytochrome
c in mitochondria and a simultaneous increase of its level in the
cytosol, indicating a translocation of cytochrome c from
mitochondria to the cytosol.
The observed loss of Dum and of cytochrome c release in
mitochondria led us to examine the status of caspases, because
they are known to link proximal and distal mitochondrial
apoptotic events. First, caspase 8 was examined, as this acts
proximally to apoptotic mitochondria (12). Western blot
showed an increase in the active form of caspase 8
(M r 20,000) (Fig. 5A), which was confirmed by enzyme assay
(Fig. 5B). Consistent with these results, Bid, its substrate
protein, was found to have been cleaved (M r 18,000) (Fig. 5A),
which is known to disrupt Dum to release cytochrome c by
opening the mitochondrial membrane pores (13). Thus, the
cleavage of Bid (Fig. 5A) is a phenomenon that is synergistic
with Bcl-2 decline (Fig. 3). We next examined caspase 9 by
Western blot because it is known that this enzyme is activated
FIGURE 1. Effect of oh8dG on the viability of KG-1 cells and oh8Gua
levels in DNA. KG-1 cells were cultured for various times with 100 Ag/ml of
oh8dG (A) or for 96 h in the presence of various concentrations of oh8dG
(B). After harvesting, cells were examined for viability using the MTT test.
At the same time, DNA was isolated from the cells and the amount of
oh8Gua (C) was determined (n = 3). Details are described in ‘‘Materials
and Methods.’’
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by cytochrome c in the cytoplasm (14). As expected, the active
form (M r 37,000) of caspase 9 was increased by Western blot
(Fig. 5A) in parallel with its activity (Fig. 5C). Finally, we
examined caspase 3, a target of caspase 9, and, as shown in
Fig. 5A, the expressions of the two active forms (M r 12,000
and 17,000) of caspase 3 increased, which was further
demonstrated by the cleavage of poly ADP-ribosyl polymerase
(PARP) from M r 115,000 to 85,000. These results indicate
that the apoptosis of KG-1 induced by oh8dG is caspase
dependent. This dependency was further examined by treating
KG-1 cells with oh8dG in the presence of benzoyloxycar-
bonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk), a general
caspase inhibitor (15) and benzoyloxycarbonyl-Asp-Glu-Val-
Asp-fluoromethylketone (zDEVD-fmk), a selective inhibitor
of caspase 3 (16). As shown in Fig. 6, these inhibitors
suppressed the formation of sub-G1 hypodiploid cells
completely (Fig. 6A) and at the same time blocked the
activation of caspase 3, as indicated by the formation of its
active forms (M r 12,000 and 17,000) and the cleavage of its
substrate PARP (Fig. 6B).
No Involvement of the Fas System and ROS
Of the caspases examined, caspase 8 was identified as the
most proximally acting enzyme. Several factors are associated
with the control of caspase 8 activity, and the Fas system has
been proposed as a major activator (17). Thus, the involve-
ment of the Fas system was tested by examining the
expressions of Fas and Fas ligand (Fas L) in oh8dG-treated
KG-1 cells. However, Fig. 7A shows no change in the number
of Fas-positive cells by flow cytometry, and Fig. 7B shows no
change in Fas-L by Western blot. These results indicate a low
likelihood of Fas system involvement. Another possibility
examined was that ROS is involved in oh8dG-induced
apoptosis. Recently, oh8dG was found to be very reactive
toward ROS (18), which suggested that oh8dG might produce
ROS during its degradation in cells. It is also known that ROS
can directly induce apoptosis (19, 20). In fact, some ROS
have been shown to be produced (Fig. 8A) by the action of
oh8dG on KG-1, but the level of ROS was too small to induce
cytotoxicity, because NAC was unable to prevent the death of
KG-1, as assessed by the MTT test (Fig. 8B), or apoptosis as
determined by the appearance of sub-G1 hypodiploid cells
(Fig. 8C).
The Relevance of oh8dG Toxicity to Low OGG1 Activity
In contrast to the KG-1 cells, U937, which is normal in
terms of OGG1 activity, was totally resistant to oh8dG,
suggesting a relation between the observed susceptibility to
oh8dG and low OGG1 activity. To test this possibility, 18 cell
lines were screened for viability using the MTT test after they
had been treated with various concentrations of oh8dG for 96 h.
FIGURE 2. Apoptosis of KG-1 cells by oh8dG. Cells were cultured with
oh8dG and examined for evidence of apoptosis using different methods.
A. Flow cytometry for the measurement of sub-G1 hypodiploid cells
(n = 3). B. Microscopy which demonstrated apoptotic bodies after
incubating with oh8dG at 50 Ag/ml for 96 h. C. Electrophoresis for the
detection of DNA fragmentation after incubating with oh8dG at 50 Ag/ml
for 96 h. Details are described in ‘‘Materials and Methods.’’
FIGURE 3. Effect of oh8dG on the expressions of Bcl-2 and Bax in KG-
1 cells. Cells were cultured with 50 Ag/ml of oh8dG for the indicated times
and subjected to electrophoresis for Western blot using mouse mono-
clonal anti-Bcl-2, -Bax, or -h-actin as a primary antibody and goat anti-
mouse IgG conjugated with horseradish peroxidase as a secondary
detection antibody. Details are described in ‘‘Materials and Methods.’’
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In addition to KG-1, another three susceptible cell lines were
found, i.e. , CEM-CM3, Molt-4, and H9 (Fig. 9A). The
sensitive cell lines proved as sensitive as KG-1, while others
showed no response to 200 Ag/ml of oh8dG. The sensitive cell
lines also showed very low OGG1 activities (Fig. 9B);
however, they showed no mutation of the OGG1 gene, reduced
OGG1 protein expression (data not shown), or an increased
amount of oh8Gua in their DNA (Fig. 9C). Moreover, the
enzyme activity and the oh8Gua levels in the DNA of resistant
cell lines were almost the same as that of U937, as shown in
Fig. 9, B and C (data not shown).
Discussion
The present study demonstrates that oh8dG induces
apoptotic cell death in cells with low OGG1 activity, and that
the concentration of oh8Gua is increased in the DNA of such
cells. In view of the fact that DNA-damaging agents have been
observed to induce apoptosis (6), the elevation of oh8Gua in
DNA might be expected to trigger apoptosis. These observa-
tions indicate that in addition to its mutagenic action, oh8Gua in
FIGURE 4. Loss of mitochondrial membrane potential (Dum) and the
release of cytochrome c from mitochondria into the cytosol in KG-1 cells
treated with oh8dG. KG-1 cells (2 105 cells/ml) were treated with 50 Ag/ml
of oh8dG for the times indicated. A. The cells harvested were incubated
with 30 mM of DiOC6(3) for 15 min at 37jC and then subjected to flow
cytometry, which used the fluorescence intensity of this fluorochrome
(n = 4). B. KG-1 cells (2  105 cells/ml) were treated with 50 Ag/ml of
oh8dG for the times indicated. The harvested cells were fractionated into
mitochondria and cytosol, as described in ‘‘Materials and Methods.’’
Aliquots of each fraction were subjected to Western blot for cytochrome c
(cyt c ). C. Cells treated as in A were analyzed for sub-G1 hypodiploid cells
by flow cytometry (n = 3).
FIGURE 5. Activation of caspases in KG-1 cells treated with oh8dG.
KG-1 was treated with 50 Ag/ml of oh8dG for the indicated times and
used for Western blot of caspases and PARP (A) and caspase assays
(n = 3); caspase 8 (B); and caspase 9 (C). Details are described in
‘‘Materials and Methods.’’
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DNA disturbs cell viability and that this may be lethal.
However, the disturbance of cell viability by increased oh8Gua
levels, as observed in the present study, is in conflict with a
report (21) that showed that the organs of OGG1-deficient mice
showed no exacerbation of toxic symptoms versus wild-type
mice at increased oh8Gua levels. Thus, the possibility that our
results might reflect an idiosyncrasy of the in vitro system used
cannot be ruled out. In addition, the oh8Gua level in
mitochondrial DNA should be considered because OGG1 is
known to play an important role in the removal of oh8Gua from
mitochondrial DNA, thus leading to a disruption of mitochon-
drial activity, which again is an important aspect of the
apoptotic process (22).
The apoptosis induced by DNA-damaging agents occurs via
two pathways: p53-dependent activation via Fas (23–25) and/or
mitochondria-mediated caspase activation (26, 27). The apop-
tosis induced by oh8dG appears to take place via the latter
pathway, because the p53 gene is inactive in KG-1 due to
mutation (28, 29) and because its expression is not changed in
oh8dG-treated KG-1 (data not shown). In addition, oh8dG-
treated KG-1 showed no change in the expression of Fas or Fas-
L (Fig. 7). On the other hand, various biochemical findings
observed in KG-1 treated with oh8dG coincide with those that
have been reported in mitochondria-involved apoptosis.
Following are the major biochemical findings observed in
the mitochondria of apoptotic cells. The first observed event
is a permeability change of the mitochondrial membrane,
which results in the release of cytochrome c to the cytosol
(30–33). Cytochrome c in the cytosol complexes with Apaf-
1 and procaspase 9 leading to the conversion of procaspase 9
into caspase 9, which in turn activates procaspase 3 to
become caspase 3 (12). Caspase 3 then activates endonu-
clease causing DNA fragmentation (34). Several factors can
alter the status of the mitochondrial membrane, and caspase 8
is probably the most active of these, which acts by cleaving
Bid, a proapoptotic member of the Bcl-2 protein family (13,
35). The cleaved Bid opens the mitochondrial membrane
pores, leading to a permeability transition (PT), which
decreases Dum, and eventually to the release of cytochrome
c into the cytosol (12). Bcl-2 prevents this mitochondrial
membrane PT (11), whereas Bax induces PT (36). In the
present study, apoptotic KG-1 provided data supporting the
above cascade. Specially, this included the following
observations: (a) a decline of Bcl-2 expression (Fig. 3); (b)
the activation of caspase 8 (Fig. 5); (c) the cleavage of Bid
(Fig. 5); (d ) decreased Dum and cytochrome c in
mitochondria and a commensurate increase in the cytosol
(Fig. 4); and (e) the activation of caspases 9 and 3 (Fig. 5).
Notably, other caspase inhibitors ceased KG-1 apoptosis by
oh8dG (Fig. 6) almost completely. As opposed to what was
expected, we found that the oh8dG level in KG-1 was
slightly higher than that in U937, which has OGG1 activity
(see Fig. 1C), which indicates that enzymes other than OGG1
may influence the oh8dG level. In contrast to OGG1, KG-1
showed normal activities of MYH and MTH1, which are two
FIGURE 6. Effect of caspase inhibitors on the apoptosis of KG-1 cells
treated with oh8dG. KG-1 was treated with oh8dG (0 or 50 Ag/ml) for 48 h
in the absence or presence of the caspase inhibitors, zVAD-fmk (50 AM),
and zDEVD-fmk (100 AM). After harvesting, KG-1 was subjected to
flow cytometric analysis for sub-G1 hypodiploid cells (A) (n = 3) and to
Western blot for caspase 3 and PARP (B). Details are described in
‘‘Materials and Methods.’’
FIGURE 7. Effect of oh8dG on the expressions of Fas and Fas-L in
KG-1 cells treated with oh8dG. KG-1 was treated in duplicate with 50 Ag/ml
of oh8dG for the indicated times. One portion of the treated KG-1 was
incubated with FITC-conjugated mouse monoclonal anti-human Fas and
subjected to the flow cytometric analysis for Fas by FITC fluorescence (A)
(n = 3). The other portion was subjected to Western blot for Fas-L (B).
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enzymes involved in repair of oh8dG (data not shown). The
former (37) removes adenine to mismatch to oh8dG, and the
latter (38) hydrolyzes oh8dGTP to oh8dGMP and thus,
prevents its incorporation into DNA. In addition, compar-
isons should be made of the cell viabilities and oh8dG
accumulations of cells with the same genetic background
with the exception of OGG1, for example, KG-1 and KG-1
expressing wild-type OGG1. In fact, a significant amount of
time was spent unsuccessfully trying to create KG-1 clones
of the latter type. KG-1 has impaired p53 activity owing to
the mutation of this gene (28, 29). Another laboratory has
made similar unsuccessful efforts to clone KG-1 expressing
wild-type p53 (39). KG-1 has a property to resist the entry of
exogenous DNA because in both laboratories, failure
occurred at transfection. Attempts are now being made by
using the antisense technique and a clone with deficient
OGG1 from NIH3T3.
FIGURE 8. The involvement of ROS in the cytotoxicity and apoptosis
of KG-1 treated with oh8dG. A. KG-1 was incubated with either oh8dG
(100 Ag/ml), H2O2 (200 AM), or NAC (2 mM) for 96 h at 37jC, and incubated
further in the presence of 2V7V-dichlorodihydrofluorescein diacetate (DCFH-
DA , 100 AM) for 1 h at 37jC in the dark. The fluorescence of 2V,7V-
dichlorofluorescein (DCF ), an oxidation product of DCFH-DA, was then
measured. B. KG-1 was incubated with oh8dG (100 Ag/ml), NAC (2 mM),
or both for the times indicated at 37jC and then subjected to an MTT test.
C. KG-1 was treated with oh8dG (100 Ag/ml), NAC (2 mM), or both for 96 h
and subjected to flow cytometric analysis for sub-G1 hypodiploid cells.
Experiments were preformed in triplicate. Details are described in
‘‘Materials and Methods.’’
FIGURE 9. The relevance of oh8dG toxicity to low OGG1 activity. A.
Eighteen cell lines including KG-1 (see ‘‘Materials and Methods’’) were
incubated with various concentrations of oh8dG for 96 h, and their viability
was then determined using the MTT test. Of the 18 cell lines, 4 cell lines,
including KG-1, found to be susceptible to oh8dG, and U937 cells,
resistant to oh8dG, were assayed for OGG1 (B) and oh8Gua levels in their
DNA (C). Experiments were preformed in triplicate. Details are described
in ‘‘Materials and Methods.’’
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Recently, we found that KG-1 and other cell lines with low
OGG1 activity show much higher sensitivity to radiation than
cells with normal OGG1 activity (6). On being exposed to g
irradiation, these cells show a higher concentration of oh8Gua-
treated cells in their DNA and undergo apoptosis. This means
that the impaired viability of oh8dG causes an elevation of the
oh8Gua level in the DNA (Fig. 1C), and also strongly
suggests that oh8Gua in the DNA is cytotoxic enough to kill
cells. Thus, cytotoxicity induced by either ROS-producing
agents or cell damage observed in the pathological conditions
accompanying high oxidative stress may contribute to this
action of oh8Gua in DNA.
It is not understood, however, how the concentration of
oh8Gua is elevated in the DNA of cells with low OGG1 activity,
as shown in Figs. 1C and 9C. This is prompted by reports that
oh8dGDP, a substrate of DNA polymerase, is not formed from
oh8dGMP, because guanylate kinase, which makes dGDP from
dGMP, does not use oh8dGMP as a substrate (40, 41). And by
our observations that 14C-labeled oh8dG was found not to be
incorporated into DNA, even though it was incorporated into
cytosol (data not shown). We observed that polymerase h,
which can incorporate dNTP with a modified base into DNA
(42) was expressed at a higher level in KG-1 than in U937, after
these cells had been treated with oh8dG. This increased
expression of polymerase h may be a reason for the elevation
of the oh8Gua level in the DNA of KG-1, because both
polymerase h expression and the elevation of oh8Gua levels
were suppressed in the presence of deoxythymidine, an
inhibitor of polymerase h (43) (data not shown). The possible
involvement of ROS as an effecter of oh8Gua elevation in DNA
was excluded by the finding that an antioxidant, NAC, has no
effect on oh8dG-induced apoptosis (Fig. 8).
This study demonstrates that oh8dG is able to elevate the
level of oh8Gua in DNA, but only in those cells with low
OGG1 activity. It further shows that cells with high levels of
oh8Gua in DNA die because of apoptosis triggered by these
elevated oh8Gua levels. From these results, it appears that
oh8Gua in DNA is toxic enough to kill cells and that oh8dG
exerts a selective lethality in OGG1-deficient cells. This
toxicity of oh8Gua in DNA may provide a mechanistic basis
for understanding the toxicities of many ROS-producing agents
and of the cell damage observed in many ROS-involved
clinical conditions. Moreover, this action may provide a
background explanation for the beneficial effects of various
antioxidants. Finally, the lethal action of oh8dG may have
applications in the selective chemotherapy of cancers with
deficient OGG1 activity because of its lack of toxicity to
normal cells.
Materials and Methods
Reagents
8-Hydroxydeoxyguanosnie (oh8dG), MTT, propidium
iodide, RNase, and Hoechst 33258 dye were purchased from
Sigma Chemical Co. (St. Louis, MO); the caspase inhibitors,
zVAD-fmk, zDEVD-fmk and the antioxidant, N-acetylcystein
(NAC), were from Calbiochem (La Jolla, CA); and DCFH-DA
was from Molecular Probes (Eugene, OR). All other reagents,
unless indicated, were from Sigma.
Cell Culture
KG-1 (human acute myelocytic leukemia cell line), U937
(human monocytic leukemia cell line), SNU-C4 (human
colorectal adenocarcinoma cell line), Hep G2 (human hepato-
blastoma cell line), SNU-1, and Kato III (human gastric cell
lines), IM-9 (human melanoma cell line), Molt-4, H9, Jurkat,
CCRF-CEM (human T lymphoblastic leukemia cell lines),
K562 (human erythrocytic leukemia cell line), and Jiyoye
(human B lymphocytic leukemia cell line) were cultured at
37jC in 5% CO2 in RPMI 1640 containing 2 mM glutamine,
10% heat-inactivated FCS, penicillin (100 units/ml), and
streptomycin (100 Ag/ml) in the absence or presence of various
concentrations of oh8dG and/or other chemicals. SK-N-SH, SH-
SY5Y, and SK-N-BE(2)C (human neuroblastoma cell lines)
and CEM-CM3 and CCRF-HSB2 (human T lymphoblastic
leukemia cell lines) were cultured under exactly the same
condition as mentioned immediately above but DMEM was
used instead of RPMI 1640.
Cell Viability Assay
The effect of oh8dG on the viability of various cancer cell
lines was determined by MTT assay (44). Cells at the
exponential phase were collected and transferred into each
well (about 104–105 cells in 180 Al/well). The cells were
incubated for various times (up to 96 h) in the presence of
various amounts of oh8dG (0–200 Ag/ml) in a total reaction
volume of 200 Al, and 50 Al of 2 mg/ml MTT solution was
then added to each well (0.1 mg/well). After incubating for 4
h, the plates were centrifuged at 800  g for 5 min and
supernatants were aspirated. The formazan crystals in each
well were dissolved in 150 Al of DMSO and the A540 was
read on a scanning multi-well spectrophotometer (Molecular
Device Co., Sunnyvale, CA). All experiments were performed
in triplicate.
Flow Cytometry
Cells were treated with oh8dG, as above, in the absence or
presence of various compounds, and flow cytometry was
performed with a FACSCalibur flow cytometer (Becton Dick-
inson, Mountain View, CA). To examine the induction of
apoptosis by oh8dG, we investigated the formation of sub-G1
hypodiploid cells (apoptotic cells). Cells (2  105 cells/ml)
were cultured with oh8dG (0–100 Ag/ml) in the absence or in
the presence of zVAD-fmk (50 AM), zDEVD-fmk (100 AM), or
NAC (2 mM), harvested at the times indicated and fixed in 1 ml
of 70% ethanol. The cells (2  105/ml) in ethanol solution were
washed twice with PBS and then incubated in the dark in 1 ml
of PBS containing 100 Ag of propidium iodide for 30 min at
37jC. The proportion of sub-G1 hypodiploid cells was
determined by using histograms generated by the Cell Quest
and Mod-Fit computer programs (8). To measure Fas
expression, cells (2  105/ml) were treated with 50 Ag/ml of
oh8dG, harvested at various times and washed twice with PBS.
The washed cells were then incubated for 2 h on ice with 20 Al
of FITC-conjugated mouse monoclonal antibody to human Fas
(DX-2; PharMingen, San Diego, CA), washed with PBS, and
subjected to flow cytometry for Fas expression by FITC
fluorescence. To determine the mitochondrial membrane
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potential (Dwm), cells (2  105 cells/ml) were treated with
50 Ag/ml of oh8dG for various times, as shown in Fig. 4, and
incubated with 30 nM of DiOC6(3) (Molecular Probes), a
cationic lipophilic fluorochrome, for 15 min at 37jC, and
subjected to flow cytometry to determine the cell distribution
by DiOC6(3) fluorescence (10).
Fluorescence Microscopy and Electrophoresis
The induction of apoptosis by oh8dG was also examined
morphologically and electrophoretically. For the former, the
same cells (2  105/ml) treated with 50 Ag/ml of oh8dG for 48 h
were washed with PBS and fixed in 4% paraformaldehyde for
5 min. The cells were then stained with Hoechst 33258 dye
(8 Ag/ml) for 5 min, washed twice with PBS, and mounted.
Nuclei were observed using an Axiovert 100 inverted
fluorescence microscope (Carl Zeiss, Oberkochen, Germany)
(9). For electrophoretic examination, the same cells (2  105/
ml) as treated above were washed with PBS, and DNA was
extracted using a genomic DNA extraction kit (Wako junyaku,
Tokyo, Japan). Aliquots of the DNA (4 Ag) dissolved in 5 Al of
a loading buffer were electrophoresed in a 1.8% agarose gel
containing 0.1 Ag/ml of ethidium bromide.
Western Blot Analysis
KG-1 (2 105 cells/ml) cells cultured with 50 Ag/ml of oh8dG
in the absence or in the presence of caspase inhibitors were
harvested at the indicated times. Cells were lysed by boiling for
5 min in 500 Al of a solution of 120 mM NaCl, 0.1% NP40,
and 40 mM Tris-HCl (pH 8.0). Aliquots of the lysates (40 Ag
of protein) were electrophoresed on a 10% SDS-polyacrylamide
gel, and the gel was transferred onto a nitrocellulose membrane
(Bio-Rad, Hercules, CA). The membrane was then incubated
with primary mouse monoclonal anti-human caspase 3, -8, -9,
and -PARP, -Bcl-2, -Bax, -Bid, -Fas ligand (Fas-L), and -h-actin
antibodies (PharMingen) and then with a secondary goat anti-
mouse IgG conjugated with horseradish peroxidase (Pierce,
Rockford, IL). The membrane was then exposed to X-ray film,
and the protein bands were detected by using an enhanced
chemiluminescence Western blotting detection kit (Amersham,
Little Chalfont, Buckinghamshire, UK).
For the detection of mitochondrial and cytosolic cytochrome
c , KG-1 cells (2  105 cells/ml) were cultured with 50 Ag/ml of
oh8dG and harvested at the times indicated in Fig. 4. The cells
were suspended in 50 Al of ice-cold homogenation buffer
[250 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1
mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, and 20 mM
HEPES (pH 7.5)] and homogenized in a Teflon homogenizer.
The homogenate was centrifuged at 750  g for 10 min at 4jC,
and the supernatant obtained was centrifuged at 10,000  g for
15 min at 4jC. The resulting pellet was resuspended in
homogenation buffer and used as a mitochondrial fraction. The
supernatant obtained by centrifuging at 10,000  g for 15 min
above was further centrifuged at 10,000  g for 60 min at
4jC and the supernatant collected was used as a cytosolic
fraction. The mitochondrial and cytosolic fractions were
analyzed by Western blot for cytochrome c as described above
using a mouse monoclonal anti-human cytochrome c antibody
(PharMingen) (45).
Caspases 8 and 9 Assays
KG-1 cells (2  105 cells/ml) were cultured with 50 Ag/ml
of oh8dG for various times and harvested. The cells were used
to assay caspases 8 and 9 by using a colorimetric kit (for
caspase 8, Clontech Laboratories, Inc., Palo Alto, CA; and for
caspase 9, R&D Systems, Minneapolis, MN) according to the
manufacturer’s instructions. The chromophore used in both
cases was p-nitroaniline (pNA), which was released from
IETD-pNA by caspase 8 and from LEHD-pNA by caspase 9.
ROS Measurements
To determine the involvement of ROS in the induction of
cytotoxicity by oh8dG, cells were treated with 100 Ag/ml of
oh8dG for 96 h and then further incubated in the presence
of 100 AM of DCFH-DA in the dark for 1 h at 37jC. To observe
the effect of the antioxidant, NAC, the reaction was performed
under the same conditions, but the cells were preincubated with
2 mM of NAC for 30 min before the oh8dG treatment. As a
positive control, cells were treated with 200 AM of H2O2 instead
of oh8dG. The fluorescence of 2V,7V-dichlorofluorescein, an
oxidation product of DCFH-DA, was measured using a
FACSCalibur flow cytometer (Becton Dickinson) (46).
oh8Gua Assay
Cells (2  105 cells/ml) cultured with oh8dG (0–100 Ag/ml)
as described above were harvested at the indicated times. DNA
was extracted from these cells by using a genomic DNA
extraction kit (Wako junyaku) and the amount of oh8Gua
present in the DNA was measured as oh8dG by using a high-
performance liquid chromatography (HPLC)/electrochemical
detector as described previously (47). The oh8dG level was
expressed as the number of oh8dG/105 deoxyguanosine (No. of
oh8dG/105 dG).
oh8Gua Glycosylase 1 Assay
To identify OGG1-deficient human leukemia cell lines,
various cell lines were cultured as described in the previous
section and screened for OGG1 activity. OGG1 was assayed
using its glycosylase activity by quantifying the oh8Gua
released from substrate DNA into the reaction medium as
described previously (44). Cells at the exponential phase were
centrifuged at 800  g for 5 min. Cell pellets (106 cells/assay)
were suspended in 2 volumes of homogenation buffer [50 mM
Tris-HCl, 50 mM KCl, 1 mM EDTA, 5% glycerol, and 0.05%
2-mercaptoethanol (pH 7.5)], and homogenized. Homogenates
were mixed with streptomycin (final concentration, 1.5%) to
remove nucleic acids, and supernatants, obtained by centrifu-
gation, were dialyzed extensively against a homogenation
buffer and used as cell extracts for the oh8Gua glycosylase
assay. To prepare the substrate for oh8Gua glycosylase, a
21-mer oligonucleotide containing oh8Gua (5V-CAGCC-
AATCAGTG*CACCATTC-3V: G*; oh8Gua) was chemically
synthesized (The Midland Certified Reagent Co., Medland,
TX), and annealed with its complementary oligonucleotide. The
duplex DNA so obtained was used as an assay substrate by
incubating this DNA (20 pmol) with the cell extracts (2 mg of
protein) at 30jC for 2 h in a 1-ml reaction mixture [50 mM Tris-
HCl, 50 mM KCl, and 1 mM EDTA (pH 7.5)]. The reaction was
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terminated by heating at 90jC for 5 min and then centrifuged at
12,000  g for 10 min. Supernatants were filtered through a
0.45-Am Millipore filter, and the filtrates were applied to
immunoaffinity columns. The pass-through fractions were
collected and reloaded. This procedure was repeated twice.
The columns were eluted with 4 ml of 100% methanol after
successive washes with 1 ml of 1 M NaCl twice, 1 ml of distilled
water three times, and 1 ml of 100% acetonitrile three times. The
eluants were dried out with a Speed-Vac (Sarvant, Holbrook,
NY) and then dissolved in 120 Al of HPLC eluting solution (10
mM NaH2PO4 in 8% methanol). Aliquots (50 Al) of dissolved
samples were analyzed by HPLC fitted with an electrochemical
detector (ESA 5100A) connected to a Beckman Ultrasphere
ODS column (5 Am 4.6 mm 25 cm). The column was eluted
with elution solution at a flow rate of 0.5 ml/min.
Statistics
Data are expressed as means F SE. The significances of
differences were evaluated using the paired Student’s t test.
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